Exact Mass: 203.1369

Exact Mass Matches: 203.1369

Found 127 metabolites which its exact mass value is equals to given mass value 203.1369, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Vernam

N,N-dipropyl(propylsulfanyl)formamide

C10H21NOS (203.1344)


   

Pebulate

N-butyl-N-ethyl(propylsulfanyl)formamide

C10H21NOS (203.1344)


   

9-methylthiononanaldoxime

9-methylthiononanaldoxime

C10H21NOS (203.1344)


   

Crotamiton

2-Butenamide, N-ethyl-N-(2-methylphenyl)-

C13H17NO (203.131)


Crotamiton is only found in individuals that have used or taken this drug. It is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. It is a colorless to slightly yellowish oil, having a faint amine-like odor. It is miscible with alcohol and with methanol.Crotamiton is an antiparasitic that is toxic to the scabies mite. Crotamiton also relieves itching by producing what is called a counter-irritation. As crotamiton evaporates from the skin, it produces a cooling effect. This cooling effect helps to divert your bodys attention away from the itching. C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D016573 - Agrochemicals D010575 - Pesticides

   

Lysylglycine

2-[(2S)-2,6-diaminohexanamido]acetic acid

C8H17N3O3 (203.127)


Lysylglycine is a dipeptide composed of lysine and glycine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glycyl-Lysine

6-Amino-2-[(2-amino-1-hydroxyethylidene)amino]hexanoate

C8H17N3O3 (203.127)


Glycyl-Lysine is a dipeptide composed of glycine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

S-(2-(N,N-Diisopropylamino)ethyl)isothiourea

[2-(Carbamimidoylsulphanyl)ethyl]bis(propan-2-yl)amine

C9H21N3S (203.1456)


   

1-(Benzofuran-5-yl)-N-ethylpropan-2-amine

[1-(1-benzofuran-5-yl)propan-2-yl](ethyl)amine

C13H17NO (203.131)


   

Lysyl-Glycine

2-[(2,6-diamino-1-hydroxyhexylidene)amino]acetic acid

C8H17N3O3 (203.127)


   

Paniculidine C

Paniculidine C

C13H17NO (203.131)


   

(-)-Aphanorphine

(-)-8-Hydroxy-1,3-dimethyl-2,3,4,5-tetrahydro-1,4-methano-3-benzazepine

C13H17NO (203.131)


   

4-Acetyl-4-phenylpiperidine

4-Acetyl-4-phenylpiperidine

C13H17NO (203.131)


   

1-(Benzofuran-5-yl)-N-ethylpropan-2-amine

1-(Benzofuran-5-yl)-N-ethylpropan-2-amine

C13H17NO (203.131)


   

Deschloroketamine

Deschloroketamine

C13H17NO (203.131)


   

UNII-LWB2M746C9

UNII-LWB2M746C9

C13H17NO (203.131)


   

Selegiline N-oxide

Selegiline N-oxide

C13H17NO (203.131)


   

alpha-Pyrrolidinopropiophenone

1-phenyl-2-pyrrolidin-1-ylpropan-1-one

C13H17NO (203.131)


   

1,3,6,6-Tetramethyl-6,7-dihydroisoquinolin-8(5H)-one

1,3,6,6-Tetramethyl-6,7-dihydroisoquinolin-8(5H)-one

C13H17NO (203.131)


   

118964-06-0

118964-06-0

C13H17NO (203.131)


   

(2Z)-N-isobutyl-2-nonene-6,8-diynamide|(Z)-non-2-en-6,8-diynoic acid isobutylamide|2-Methylpropylamide-2-Phenylethylamide-(Z)-2-Nonene-6,8-diynoic acid

(2Z)-N-isobutyl-2-nonene-6,8-diynamide|(Z)-non-2-en-6,8-diynoic acid isobutylamide|2-Methylpropylamide-2-Phenylethylamide-(Z)-2-Nonene-6,8-diynoic acid

C13H17NO (203.131)


   

2-(3H-indol-3-ylmethyl)butan-1-ol

2-(3H-indol-3-ylmethyl)butan-1-ol

C13H17NO (203.131)


   

R-Deprenyl N-Oxide

R-Deprenyl N-Oxide

C13H17NO (203.131)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3461 CONFIDENCE standard compound; INTERNAL_ID 2117

   

Crotamiton

(E)-N-ethyl-N-(2-methylphenyl)but-2-enamide

C13H17NO (203.131)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D016573 - Agrochemicals D010575 - Pesticides CONFIDENCE standard compound; INTERNAL_ID 650; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8954; ORIGINAL_PRECURSOR_SCAN_NO 8953 CONFIDENCE standard compound; INTERNAL_ID 650; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8989; ORIGINAL_PRECURSOR_SCAN_NO 8988 CONFIDENCE standard compound; INTERNAL_ID 650; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9012; ORIGINAL_PRECURSOR_SCAN_NO 9011 CONFIDENCE standard compound; INTERNAL_ID 650; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9032; ORIGINAL_PRECURSOR_SCAN_NO 9030 CONFIDENCE standard compound; INTERNAL_ID 650; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9049; ORIGINAL_PRECURSOR_SCAN_NO 9047 CONFIDENCE standard compound; INTERNAL_ID 650; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9054; ORIGINAL_PRECURSOR_SCAN_NO 9053 CONFIDENCE standard compound; INTERNAL_ID 2699 CONFIDENCE standard compound; INTERNAL_ID 8580 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3200

   

DEP_204.1383_10.9

DEP_204.1383_10.9

C13H17NO (203.131)


CONFIDENCE Transformation product with Reference Standard (Level 1); INTERNAL_ID 501

   
   
   

Gly-lys

2-(2,6-diaminohexanamido)acetic acid

C8H17N3O3 (203.127)


A dipeptide formed from glycine and L-lysine residues.

   

Lys-gly

6-amino-2-(2-aminoacetamido)hexanoic acid

C8H17N3O3 (203.127)


A dipeptide formed from L-lysine and glycine residues.

   

5-methoxy-2,3-dihydrospiro[indene-1,2-pyrrolidine]

5-methoxy-2,3-dihydrospiro[indene-1,2-pyrrolidine]

C13H17NO (203.131)


   

(4-methylphenyl)-piperidin-4-ylmethanone

(4-methylphenyl)-piperidin-4-ylmethanone

C13H17NO (203.131)


   

1-(4-FLUOROBENZYL)PIPERIDIN-4-AMINE

1-(4-FLUOROBENZYL)PIPERIDIN-4-AMINE

C12H17N3 (203.1422)


   

1-Benzyl-azepan-3-one

1-Benzyl-azepan-3-one

C13H17NO (203.131)


   

3-Methyl-3H-spiro[isobenzofuran-1,4-piperidine] hydrochloride

3-Methyl-3H-spiro[isobenzofuran-1,4-piperidine] hydrochloride

C13H17NO (203.131)


   

(2-CYANOPHENYL)ACETONE

(2-CYANOPHENYL)ACETONE

C9H21N3S (203.1456)


   

1-Cyclohexyl-2-pyridin-2-yl-ethanone

1-Cyclohexyl-2-pyridin-2-yl-ethanone

C13H17NO (203.131)


   

5,6-Dihydro-2-phenyl-4,4,6-trimethyl-1,3(4H)-oxazine

5,6-Dihydro-2-phenyl-4,4,6-trimethyl-1,3(4H)-oxazine

C13H17NO (203.131)


   

2-Methyl-2-propanyl (2S)-2-(fluoromethyl)-1-pyrrolidinecarboxylat e

2-Methyl-2-propanyl (2S)-2-(fluoromethyl)-1-pyrrolidinecarboxylat e

C10H18FNO2 (203.1322)


   

1-Benzyl-4-methyl-3-piperidinone

1-Benzyl-4-methyl-3-piperidinone

C13H17NO (203.131)


   

(1-BENZYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)METHANOL

(1-BENZYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)METHANOL

C13H17NO (203.131)


   

4-hexoxybenzonitrile

4-hexoxybenzonitrile

C13H17NO (203.131)


   

(3S)-3-(1-methylindol-3-yl)butan-1-ol

(3S)-3-(1-methylindol-3-yl)butan-1-ol

C13H17NO (203.131)


   

1,3,7-tris(trideuteriomethyl)purine-2,6-dione

1,3,7-tris(trideuteriomethyl)purine-2,6-dione

C8HD9N4O2 (203.1369)


   

3,4-Dihydrospiro[chromene-2,4-piperidine]

3,4-Dihydrospiro[chromene-2,4-piperidine]

C13H17NO (203.131)


   

1-Benzyl-4-azepanone

1-Benzyl-4-azepanone

C13H17NO (203.131)


   

UNII:4956DJR58O

Mecamylamine hydrochloride

C11H22ClN (203.1441)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist Mecamylamine hydrochloride is an orally active, nonselective, noncompetitive nAChR antagonist. Mecamylamine hydrochloride is also a ganglionic blocker. Mecamylamine hydrochloride can across the blood-brain barrier. Mecamylamine hydrochloride can be used in the research of neuropsychiatric disorders, hypertension, antidepressant area[1][2][5].

   

1-benzyl-2-methylpiperidin-4-one

1-benzyl-2-methylpiperidin-4-one

C13H17NO (203.131)


   

(S)-2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethylamine

(S)-2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethylamine

C13H17NO (203.131)


   

3H-SPIRO[AZEPANE-4,1-ISOBENZOFURAN]

3H-SPIRO[AZEPANE-4,1-ISOBENZOFURAN]

C13H17NO (203.131)


   

2-(4-(Pentyloxy)phenyl)acetonitrile

2-(4-(Pentyloxy)phenyl)acetonitrile

C13H17NO (203.131)


   

3-[2-(Dimethylamino)ethyl]-1H-indol-5-amine

3-[2-(Dimethylamino)ethyl]-1H-indol-5-amine

C12H17N3 (203.1422)


   

Triethylmethylammonium Tetrafluoroborate

Triethylmethylammonium Tetrafluoroborate

C7H18BF4N (203.1468)


   

4-((e)-3-phenyl-allyl)-morpholine

4-((e)-3-phenyl-allyl)-morpholine

C13H17NO (203.131)


   

tert-butyl 4-fluoropiperidine-1-carboxylate

tert-butyl 4-fluoropiperidine-1-carboxylate

C10H18FNO2 (203.1322)


   

Cyclopropanamine, 1-[3-(tetrahydro-2-furanyl)phenyl]

Cyclopropanamine, 1-[3-(tetrahydro-2-furanyl)phenyl]

C13H17NO (203.131)


   

Cyclopropanamine, 1-[3-(tetrahydro-3-furanyl)phenyl]

Cyclopropanamine, 1-[3-(tetrahydro-3-furanyl)phenyl]

C13H17NO (203.131)


   

1H-Pyrrolo[2,3-b]pyridine-3-methanamine,6-ethyl-N,N-dimethyl-(9CI)

1H-Pyrrolo[2,3-b]pyridine-3-methanamine,6-ethyl-N,N-dimethyl-(9CI)

C12H17N3 (203.1422)


   

3H-SPIRO[1-BENZOFURAN-2,4-(1-METHYLPIPERIDINE)]

3H-SPIRO[1-BENZOFURAN-2,4-(1-METHYLPIPERIDINE)]

C13H17NO (203.131)


   

1-methyl-7-pyridin-3-yl-1,7-diazaspiro[3.4]octane

1-methyl-7-pyridin-3-yl-1,7-diazaspiro[3.4]octane

C12H17N3 (203.1422)


   

(S)-(-)-2-(a-(i-butyl)methanamine)-1H-benzimidazole, min. 98 (S)-i-Bu-BIMAH

(S)-(-)-2-(a-(i-butyl)methanamine)-1H-benzimidazole, min. 98 (S)-i-Bu-BIMAH

C12H17N3 (203.1422)


   

1-(1-BENZYL-PYRROLIDIN-3-YL)-ETHANON

1-(1-BENZYL-PYRROLIDIN-3-YL)-ETHANON

C13H17NO (203.131)


   

2-(3alpha-Propan-2-yl-3-indolyl)ethanol

2-(3alpha-Propan-2-yl-3-indolyl)ethanol

C13H17NO (203.131)


   

tert-Butyl (3-hydrazino-3-oxopropyl)carbamate

tert-Butyl (3-hydrazino-3-oxopropyl)carbamate

C8H17N3O3 (203.127)


   

ANTI-7-HYDROXY-2-BENZYL-2-AZABICYCLO2.2.1HEPTANE

ANTI-7-HYDROXY-2-BENZYL-2-AZABICYCLO2.2.1HEPTANE

C13H17NO (203.131)


   

tert-Butyl [(3Z)-3-amino-3-(hydroxyimino)propyl]-carbamate

tert-Butyl [(3Z)-3-amino-3-(hydroxyimino)propyl]-carbamate

C8H17N3O3 (203.127)


   

4-Piperidinoacetophenone

4-Piperidinoacetophenone

C13H17NO (203.131)


   

4-(piperidin-1-ylmethyl)benzaldehyde

4-(piperidin-1-ylmethyl)benzaldehyde

C13H17NO (203.131)


   

4-Octyl-3-thiosemicarbazide

4-Octyl-3-thiosemicarbazide

C9H21N3S (203.1456)


   

3-(PIPERIDINOMETHYL)BENZALDEHYDE

3-(PIPERIDINOMETHYL)BENZALDEHYDE

C13H17NO (203.131)


   

(2R)-4-(1H-Indol-3-yl)-2-methyl-1-butanol

(2R)-4-(1H-Indol-3-yl)-2-methyl-1-butanol

C13H17NO (203.131)


   

3-Benzyl-8-oxa-3-azabicyclo[3.2.1]octane

3-Benzyl-8-oxa-3-azabicyclo[3.2.1]octane

C13H17NO (203.131)


   

2-Ethoxy-4-(2-methyl-2-propanyl)benzonitrile

2-Ethoxy-4-(2-methyl-2-propanyl)benzonitrile

C13H17NO (203.131)


   

2,6-di-iso-propylphenyl isocyanate

2,6-di-iso-propylphenyl isocyanate

C13H17NO (203.131)


   

1-Oxa-6-azaspiro[2.5]octane,6-(phenylmethyl)-

1-Oxa-6-azaspiro[2.5]octane,6-(phenylmethyl)-

C13H17NO (203.131)


   

1-Phenyl-3-(1-pyrrolidinyl)-1-propanone

1-Phenyl-3-(1-pyrrolidinyl)-1-propanone

C13H17NO (203.131)


   

trans-4-(Diethylamino)cinnamaldehyde

trans-4-(Diethylamino)cinnamaldehyde

C13H17NO (203.131)


   

(3R)-(-)-3-(1-Methyl-1H-Indol-3-yl)-1-Butanol

(3R)-(-)-3-(1-Methyl-1H-Indol-3-yl)-1-Butanol

C13H17NO (203.131)


   

2-(2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl)ethanamine

2-(2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl)ethanamine

C13H17NO (203.131)


   

2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine

2-(7-methoxy-3,4-dihydronaphthalen-1-yl)ethan-1-amine

C13H17NO (203.131)


   

(E)-2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethan-1-amine

(E)-2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethan-1-amine

C13H17NO (203.131)


   

N-(1-Methylethyl)-N-(phenylmethyl)-2-propenamide

N-(1-Methylethyl)-N-(phenylmethyl)-2-propenamide

C13H17NO (203.131)


   

1-ISOPROPYL-1,2,3,4-TETRAHYDRO-QUINOLINE-6-CARBALDEHYDE

1-ISOPROPYL-1,2,3,4-TETRAHYDRO-QUINOLINE-6-CARBALDEHYDE

C13H17NO (203.131)


   

TERT-BUTYL (2-HYDRAZINYL-2-OXOETHYL)(METHYL)CARBAMATE

TERT-BUTYL (2-HYDRAZINYL-2-OXOETHYL)(METHYL)CARBAMATE

C8H17N3O3 (203.127)


   

4-amino-3-(tert-butylamino)-2-methylbenzonitrile

4-amino-3-(tert-butylamino)-2-methylbenzonitrile

C12H17N3 (203.1422)


   

1-Benzylpiperidine-4-carbaldehyde

1-Benzylpiperidine-4-carbaldehyde

C13H17NO (203.131)


   

1-Phenethyl-4-piperidone

1-Phenethyl-4-piperidone

C13H17NO (203.131)


   

2-METHYL-4-PIPERIDIN-1-YL-BENZALDEHYDE

2-METHYL-4-PIPERIDIN-1-YL-BENZALDEHYDE

C13H17NO (203.131)


   

7-Methoxy-2,2,4-trimethyl-1,2-dihydroquinoline

7-Methoxy-2,2,4-trimethyl-1,2-dihydroquinoline

C13H17NO (203.131)


   

1H-Inden-1-one,2-amino-2,3-dihydro-4,5,6,7-tetramethyl-(9CI)

1H-Inden-1-one,2-amino-2,3-dihydro-4,5,6,7-tetramethyl-(9CI)

C13H17NO (203.131)


   

2,6-DICHLORO-4-NITROANISOLE

2,6-DICHLORO-4-NITROANISOLE

C13H17NO (203.131)


   

4-Benzylaminocyclohexanone

4-Benzylaminocyclohexanone

C13H17NO (203.131)


   

1-Benzyl-3-methyl-4-piperidinone

1-Benzyl-3-methyl-4-piperidinone

C13H17NO (203.131)


   

5-(tert-Butyl)-2-ethylbenzoxazole

5-(tert-Butyl)-2-ethylbenzoxazole

C13H17NO (203.131)


   

Spiro[isochroman-1,4-piperidine]

Spiro[isochroman-1,4-piperidine]

C13H17NO (203.131)


   

Dexmecamylamine hydrochloride

Dexmecamylamine hydrochloride

C11H22ClN (203.1441)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist

   

S-(2-(N,N-Diisopropylamino)ethyl)isothiourea

S-(2-(N,N-Diisopropylamino)ethyl)isothiourea

C9H21N3S (203.1456)


   

Glycyllysine

Glycyllysine

C8H17N3O3 (203.127)


   

Glycyl-isolysine

Glycyl-isolysine

C8H17N3O3 (203.127)


   

9-(Methylsulfanyl)nonanal oxime

9-(Methylsulfanyl)nonanal oxime

C10H21NOS (203.1344)


   

N(alpha)-acetyl-L-lysine methyl ester(1+)

N(alpha)-acetyl-L-lysine methyl ester(1+)

C9H19N2O3+ (203.1396)


   

3-methyl-N-(2-phenylethyl)-2-butenamide

3-methyl-N-(2-phenylethyl)-2-butenamide

C13H17NO (203.131)


   

L-Leucine, trimethylsilyl ester

L-Leucine, trimethylsilyl ester

C9H21NO2Si (203.1341)


   

l-Isoleucine, trimethylsilyl ester

l-Isoleucine, trimethylsilyl ester

C9H21NO2Si (203.1341)


   

N(epsilon)-carbamoylmethyllysine

N(epsilon)-carbamoylmethyllysine

C8H17N3O3 (203.127)


   

beta-Alanyl-ornithine

beta-Alanyl-ornithine

C8H17N3O3 (203.127)


   

N-[(4-aminophenyl)methyl]-2,3,4,5-tetrahydropyridin-6-amine

N-[(4-aminophenyl)methyl]-2,3,4,5-tetrahydropyridin-6-amine

C12H17N3 (203.1422)


   

4-(Dimethylamino)butyric acid, TMS derivative

4-(Dimethylamino)butyric acid, TMS derivative

C9H21NO2Si (203.1341)


   

N-[2-Methyl-1-(trimethylsilyloxy)propan-2-yl]acetamide

N-[2-Methyl-1-(trimethylsilyloxy)propan-2-yl]acetamide

C9H21NO2Si (203.1341)


   
   
   

Lysylglycine

Lysylglycine

C8H17N3O3 (203.127)


   

lysyl-glycine

lysyl-glycine

C8H17N3O3 (203.127)


   

N(6)-glycyl-L-lysine

N(6)-glycyl-L-lysine

C8H17N3O3 (203.127)


A L-lysine derivative with a glycyl group at the N(6)-position.

   

Methylthiononanaldoxime

Methylthiononanaldoxime

C10H21NOS (203.1344)


   

ALDH1A3-IN-2

ALDH1A3-IN-2

C13H17NO (203.131)


ALDH1A3-IN-2 (Compound 15) is a potent inhibitor of ALDH1A3 with an IC50 of 1.29 μM. Aldehyde dehydrogenases (ALDHs) are overexpressed in various tumor types including prostate cancer. ALDH1A3-IN-2 has the potential for the research of cancer diseases[1].

   

(1s,9s)-1,10-dimethyl-10-azatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-trien-4-ol

(1s,9s)-1,10-dimethyl-10-azatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-trien-4-ol

C13H17NO (203.131)


   

(2z)-n-(2-methylpropyl)non-2-en-6,8-diynimidic acid

(2z)-n-(2-methylpropyl)non-2-en-6,8-diynimidic acid

C13H17NO (203.131)


   
   

n-(2-methylpropyl)-3-phenylprop-2-enimidic acid

n-(2-methylpropyl)-3-phenylprop-2-enimidic acid

C13H17NO (203.131)


   

(2r)-4-(1h-indol-3-yl)-2-methylbutan-1-ol

(2r)-4-(1h-indol-3-yl)-2-methylbutan-1-ol

C13H17NO (203.131)


   

1-phenyl-2-[(2s)-piperidin-2-yl]ethanone

1-phenyl-2-[(2s)-piperidin-2-yl]ethanone

C13H17NO (203.131)


   

1,10-dimethyl-10-azatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-trien-4-ol

1,10-dimethyl-10-azatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-trien-4-ol

C13H17NO (203.131)


   

5-[(2,4-dimethylphenyl)methyl]-4,5-dihydro-3h-pyrrol-2-ol

5-[(2,4-dimethylphenyl)methyl]-4,5-dihydro-3h-pyrrol-2-ol

C13H17NO (203.131)


   

4-(1h-indol-3-yl)-2-methylbutan-1-ol

4-(1h-indol-3-yl)-2-methylbutan-1-ol

C13H17NO (203.131)


   

(2s)-4-(1h-indol-3-yl)-2-methylbutan-1-ol

(2s)-4-(1h-indol-3-yl)-2-methylbutan-1-ol

C13H17NO (203.131)


   

1-phenyl-2-(piperidin-2-yl)ethanone

1-phenyl-2-(piperidin-2-yl)ethanone

C13H17NO (203.131)


   

n-(2-methylpropyl)non-2-en-6,8-diynimidic acid

n-(2-methylpropyl)non-2-en-6,8-diynimidic acid

C13H17NO (203.131)